Skip to content
value.today

Genten Therapeutics, Inc.

Total raised
$12 M
1 round on record
Latest round
$12 M
Sep 2016
First round on record
Sep 2016
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Genten Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2016$12 MNo. 1$10 to $50 million

Genten Therapeutics, Inc.: Raise no. 1, Sep 2016

Investors in this round

3 investors had bought by the notice of Oct 3, 2016: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $22 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Craig Johnson · Executive Officer, Director
  • David Mauney · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edward Y. Kim, Assistant Secretary. Newest notice filed Oct 3, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Genten Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2016).

    SEC Form D · Oct 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2016

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Genten Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Genten Therapeutics, Inc.
NameRoleNamed in
Craig JohnsonExecutive officerOct 2016
David MauneyExecutive officerOct 2016
Craig JohnsonDirectorOct 2016
David MauneyDirectorOct 2016